The way I see this is simple:
Current share price doesn't reflect the current development of science we own. Many valuations are saying $31.00+
If you add another rare disease to the mix, this valuation will increase the new valuation.
If you add in 3 more positive breakthroughs, the share valuation would be in excess of $100.00.
So, if the current share price is $22.57, there is certainly only extreme upside. We are trading in profit, we expect these profits to grow exponentially and with new disease being treated, the current share price has a very long way to go, to get to a point of stabilisation.
For me, it's one of the most simple stock picks around to generate further profits.
xoxo
Merry Christmas all.
- Forums
- ASX - By Stock
- NEU
- Take Over Opportunity
Take Over Opportunity
-
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B |
Open | High | Low | Value | Volume |
$20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 249 | $20.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.31 | 790 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 249 | 20.150 |
2 | 815 | 20.110 |
1 | 99 | 20.100 |
1 | 912 | 20.090 |
1 | 790 | 20.070 |
Price($) | Vol. | No. |
---|---|---|
20.310 | 790 | 1 |
20.350 | 790 | 1 |
20.390 | 1640 | 2 |
20.420 | 790 | 1 |
20.580 | 2400 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |